How a Big Pharma Company Stalled a Potentially Lifesaving Vaccine in Pursuit of Bigger Profits
By Anna Maria Barry-Jester | - ( ProPublica) - Ever since he was a medical student, Dr. Neil Martinson has …
Stay updated with breaking news from Luc Debruyne. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Anna Maria Barry-Jester | - ( ProPublica) - Ever since he was a medical student, Dr. Neil Martinson has …
CityWatch is published 24/7 with special e-news blasts on Monday and Thursday evening, with Extras as appropriate around special events such as elections or imp
Tuberculosis remains a ‘poor’ disease that mostly afflicts those living in developing countries.
A vaccine against tuberculosis, the world’s deadliest infectious disease, has never been closer to reality, with the potential to save millions of lives. But its development slowed after its corporate owner focused on more profitable vaccines.
A vaccine against tuberculosis, the world’s deadliest infectious disease, has never been closer to reality, with the potential to save millions of lives. But its development slowed after its corporate owner focused on more profitable vaccines.